Orthocell Ltd (AU:OCC) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Orthocell Ltd has announced the cessation of 320,000 options due to expiry without exercise or conversion as of October 14, 2024. The biotechnology firm’s notification indicates a change in its capital structure, a detail that might interest investors tracking their investment or considering buying into the company.
For further insights into AU:OCC stock, check out TipRanks’ Stock Analysis page.